Skopos Bio raises $8.4M seed to advance radioactive cancer therapy
Melbourne oncology startup Skopos Bio has raised a seed round from Tenmile, Tin Alley Ventures and Yosemite to advance radioactive cancer therapy toward human trials.
Investment Committee, Tin Alley Ventures · angel in 1 deal
| Role | Organisation | Sources |
|---|---|---|
| Founder | Tanarra Capital | Sandon Capital, Startup Daily |
| Investment Committee | Tin Alley Ventures | Startup Daily, SmartCompany, Dealroom, Tin Alley Ventures team page |
Every published round John Wylie took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Affinda | Unnamed stage | Nov 2024 | $10m | Participant | Startup Daily, SmartCompany, Forbes Australia |
Companies John Wylie has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Affinda | AI-powered document processing platform integrating with ERP systems like Microsoft Dynam… | Nov 2024 | 1 | 0 |
Fund closes reported for John Wylie, as distinct from the investments it has made.
Companies John Wylie has backed that another company then bought. An exit for the holding, not a deal John Wylie did.
Stories naming John Wylie. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne oncology startup Skopos Bio has raised a seed round from Tenmile, Tin Alley Ventures and Yosemite to advance radioactive cancer therapy toward human trials.
Tennis Australia's venture arm AO Ventures has reached a first close on its new sports, media and health tech fund with about $49 million committed by local and international backers.
Melbourne document-AI firm Affinda, founded by Tim and Ben Toner, closed a $10m round from family offices and wealthy individuals after an earlier $13m raise; Deloitte ranked it the nation's fastest-growing AI company.
Analysis of rising shareholder activism: Lendlease's chairman departs under Tanarra pressure, activists push Karoon over dividends, Tanarra surfaces on Bapcor's register, and L1 Capital runs an activist fund.
University of Melbourne launches a $15m pre-seed fund with Breakthrough Victoria and a $100m fund run by Tanarra Capital for research commercialisation; the piece also recalls ANU's Instaclustr sale to NetApp.